Skip to main content
SP5007,798.99+0.65%DOW53,839.99+0.13%NASDAQ26,803.03+0.81%BTC$62,826.00-1.14%ETH$1,874.99-0.38%GOLD$4,407.30-0.30%OIL$81.83+0.71%
Smart Investors Daily
Sign InSign Up Free
HS

NASDAQ · HSCS

HeartSciences Inc.

Healthcare · Medical - Devices

$2.06

Up+$0.06 (+3.00%)

Updated Aug 14, 2026, 9:35 AM

SID Score

3.0/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
5.97M
P/E ratio
-0
Dividend yield
0.00%
52-week range
$1.63 – $3.93
Volume
9.11K
Avg. volume
52.92K

Price performance

HSCS price history

1M range · 21 trading sessions · Daily adjusted prices

HSCS closed at $2.06 after 21 trading sessions, down 24.82% for the selected period.

Last close
$2.06
Period change
-24.82%
Period low
$2.00
Period high
$2.74
Daily close
View OHLC price history
HSCS OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Aug 13, 2026$2.015$2.125$2.015$2.069.11K
Aug 12, 2026$2.03$2.08$1.99$2.0018.51K
Aug 11, 2026$2.03$2.09$2.03$2.0513.1K
Aug 10, 2026$2.02$2.17$1.93$2.07122.43K
Aug 7, 2026$2.02$2.16$1.985$2.02170.15K
Aug 6, 2026$2.2054$2.25$2.00$2.0044.75K
Aug 5, 2026$2.08$2.29$2.08$2.2874.5K
Aug 4, 2026$2.21$2.29$2.01$2.08136.73K
Aug 3, 2026$2.16$2.28$2.0924$2.1457.06K
Jul 31, 2026$2.03$2.40$1.98$2.1841.29K
Jul 30, 2026$2.00$2.17$2.00$2.0869.49K
Jul 29, 2026$2.19$2.30$1.85$2.1673.26K
Jul 28, 2026$2.45$2.5375$2.25$2.2682.92K
Jul 27, 2026$2.36$2.53$2.36$2.5383.99K
Jul 24, 2026$2.44$2.58$2.36$2.398.21K
Jul 23, 2026$2.56$2.56$2.24$2.4436.19K
Jul 22, 2026$2.39$2.61$2.39$2.5033.71K
Jul 21, 2026$2.56$2.56$2.38$2.4623.25K
Jul 20, 2026$2.60$2.615$2.50$2.5714.88K
Jul 17, 2026$2.76$2.76$2.54$2.6928.46K
Jul 16, 2026$2.53$2.90$2.43$2.74104K

Latest HSCS news

The latest Smart Investors Daily articles mentioning HSCS.

Stock researchCompany · Overview

HSCS research

Overview

Company profile and research snapshot.

Company profile

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$3.00
Implied upside
—
Analysts
—
HSCS recent ratings
DateFirmRatingTarget
Mar 24, 2026Ascendiant CapitalBuy—
Dec 22, 2025Ascendiant CapitalBuy—
Oct 1, 2025Ascendiant CapitalBuy—
Mar 18, 2025Ascendiant CapitalBuy—
Dec 18, 2024Maxim GroupBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Jul 29, 2026

HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results

Company believes proposed Fortitude Mining Holdings business combination represents a significant value creation opportunity for the Company’s shareholders Fiscal 2026 saw the full commercial launch of the MyoVista Insights platform and submission of the MyoVista wavECG device to the FDA for 510(k) clearance Southlake, TX, July 29, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on a

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By